INSM: Q2 Earnings Call @ 08:30 ET Today [delayed] -
Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008 -
INSM: To Present At IBC Life Sciences DDT 2008 Conference @ 09:25 ET [delayed] -
Jim Miller, Ph.D. Joins Insmed Therapeutic Proteins as Vice President of Process Development -
Insmed to Host Second Quarter 2008 Conference Call -
Insmed CEO to Present at Drug Discovery & Development Conference -
Insmed Provides Update on IPLEX(TM) Programs -
Insmed Partners With Bill Thomas, Former House Ways and Means Chairman, as Strategic Advisor -
Insmed retains RBC Capital as strategic advisor -
Insmed Retains RBC Capital Markets as Strategic Financial Advisor -
Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company -
INSM: To Request Hearing re Nasdaq Delisting Notice -
Insmed to Request Hearing Before NASDAQ Panel to Review NASDAQ Staff Determination -
Insmed Inc. (INSM) Corporate Event Announcement Notice -
Insmed Inc. (INSM) Corporate Event Announcement Notice -
Insmed Inc. (INSM) Corporate Event Announcement Notice -
/C O R R E C T I O N -- Insmed Inc./ -
INSM: Q1 Earnings Call @ 08:30 ET Today [delayed] -
Insmed Announces First Quarter 2008 Financial Results -
INSM: To Present At CBI Follow-On Biologics Conference @ 14:15 ET [delayed] -